These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17404175)
1. Upregulation of nitric oxide, inhibition of oxidative stress, and antihypertensive effects of statins. Zhou MS Hypertension; 2007 Jun; 49(6):e43; author reply e44. PubMed ID: 17404175 [No Abstract] [Full Text] [Related]
2. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Zhou MS; Schuman IH; Jaimes EA; Raij L Am J Physiol Renal Physiol; 2008 Jul; 295(1):F53-9. PubMed ID: 18463318 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. Kishi T; Hirooka Y; Mukai Y; Shimokawa H; Takeshita A J Hypertens; 2003 Feb; 21(2):379-86. PubMed ID: 12569269 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension. Zhou MS; Tian R; Jaimes EA; Raij L Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709 [TBL] [Abstract][Full Text] [Related]
5. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. Zhou MS; Jaimes EA; Raij L Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570 [TBL] [Abstract][Full Text] [Related]
6. A pharmacogenomic study of atorvastatin effects on eNOS activity: do "statins" modulate blood nitrite levels and intravascular oxidant stress in susceptible individuals? Dezfulian C; Raat NJ; Gladwin MT Free Radic Biol Med; 2006 Oct; 41(7):1041-3. PubMed ID: 16962928 [No Abstract] [Full Text] [Related]
7. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Kishi T; Hirooka Y; Shimokawa H; Takeshita A; Sunagawa K Clin Exp Hypertens; 2008 Jan; 30(1):3-11. PubMed ID: 18214729 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372 [TBL] [Abstract][Full Text] [Related]
9. Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress. Kuklińska AM; Mroczko B; Musiał WJ; Sawicki R; Kozieradzka A; Usowicz-Szaryńska M; Kamiński K; Knapp M; Szmitkowski M Pharmacol Rep; 2010; 62(5):883-90. PubMed ID: 21098871 [TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats. Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of raloxifene and atorvastatin on serum lipids. Tsakok AD J Obstet Gynaecol; 2005 Feb; 25(2):228. PubMed ID: 15814427 [No Abstract] [Full Text] [Related]
12. HMG-CoA reductase inhibitors and renal function. Campese VM; Park J Clin J Am Soc Nephrol; 2007 Nov; 2(6):1100-3. PubMed ID: 17942762 [No Abstract] [Full Text] [Related]
13. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411 [TBL] [Abstract][Full Text] [Related]
15. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity. El-Moselhy MA; El-Sheikh AA Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999 [TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats. Yao L; Chen GP; Lu X; Zheng LR; Mou Y; Hu SJ Basic Res Cardiol; 2009 May; 104(3):258-68. PubMed ID: 18836677 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin attenuates oxidative stress in patients with chronic kidney disease. Renke M; Knap N; Tylicki L; Rutkowski P; Neuwelt A; Larczynski W; Wozniak M; Rutkowski B Med Sci Monit; 2010 Mar; 16(3):LE3-3. PubMed ID: 20190691 [No Abstract] [Full Text] [Related]
18. Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis. Lecian D; Demova H; Lodererova A; Zdychova J; Kluckova H; Teplan V; Voska L; Komers R Kidney Blood Press Res; 2006; 29(3):135-43. PubMed ID: 16899993 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner. Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats. Ito D; Ito O; Mori N; Muroya Y; Cao PY; Takashima K; Kanazawa M; Kohzuki M J Hypertens; 2010 Nov; 28(11):2278-88. PubMed ID: 20724941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]